Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 01/28/2022
| Panel Member | Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent | Spouse/Domestic Partner/Dependent Potential Conflict | Date Completed |
|---|---|---|---|---|---|---|
| Kehinde Adekola MD,MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN | None | None | None | NA | 01/05/2022 |
| Larry Anderson, Jr. MD,PhD | Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
Celgene Corporation GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
None | NA | 01/20/2021 |
| Muhamed Baljevic MD | None | None | Bristol-Myers Squibb Company Cardinal Health CurioScience Janssen Biotech, Inc. Karyopharm Therapeutics NCCN 2020 Virtual Congress: Hematologic Malignancies Oncopeptides Inc. Sanofi-Genzyme |
None | NA | 11/09/2021 |
| Ryan Berardi MSc | None | None | None | None | NA | 01/21/2022 |
| Marian Birkeland PhD | None | None | None | None | NA | 10/22/2021 |
| Natalie Callander MD | None | None | None | None | NA | 12/26/2021 |
| Erica Campagnaro MD | None | None | None | None | NA | 02/02/2021 |
| Jorge Castillo MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | NA | 12/19/2021 |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | NA | 01/27/2022 |
| Eileen Cucinotta | None | None | None | None | NA | 01/28/2022 |
| Christopher D'Angelo MD | BeiGene Fate Therapeutics Karyopharm Therapeutics |
TG Therapeutics | None | None | NA | 08/19/2021 |
| Srinivas Devarakonda MD | None | None | None | None | NA | 08/20/2021 |
| Sarah DeVincenzo PharmD,BCPS | None | None | None | None | NA | 11/09/2021 |
| Noura Elsedawy MD | None | None | None | Vyriad | NA | 06/20/2021 |
| Colleen Erb MSN,RN,AOCNP | None | None | None | None | NA | 11/08/2021 |
| Alfred Garfall MD | CRISPR Therapeutics Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
Amgen Inc. Janssen Pharmaceutica Products, LP Legend Bio |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | NA | 01/12/2022 |
| Kelly Godby MD | None | None | None | None | NA | 08/16/2021 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | NA | 11/11/2021 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | NA | 01/26/2022 |
| Jens Hillengass MD,PhD | Amgen Inc. Bristol-Myers Squibb Company Gilead Sciences, Inc. GlaxoSmithKline HARPOON Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
Aptitude Health GlaxoSmithKline Janssen Pharmaceutica Products, LP Oncopeptides sanofi-aventis U.S. Skyline |
Amgen Inc. Beijing Medical Award Foundation Curio Science Patient Partners Rapid Payer Response Research to Practice |
None | NA | 12/06/2021 |
| Leona Holmberg MD,PhD | Bristol-Myers Squibb Company Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | NA | 01/20/2022 |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | NA | 01/10/2022 |
| Carol Ann Huff MD | Glenmark / Ichnos | AstraZeneca Pharmaceuticals LP GlaxoSmithKline Oncopeptides sanofi-aventis U.S. |
None | None | NA | 08/11/2021 |
| Malin Hultcrantz MD,PhD | Amgen Inc. Daiichi- Sankyo Co. GlaxoSmithKline |
None | Bristol-Myers Squibb Company | None | NA | 10/18/2021 |
| Yubin Kang MD | None | None | None | None | NA | 12/05/2021 |
| Rashmi Kumar PhD | None | None | None | None | NA | 10/18/2021 |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Carsgen GlaxoSmithKline MedImmune Inc. Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. BeiGene Bluebird Bristol-Myers Squibb Company Epizyme GlaxoSmithKline GLH Pharma Oncopeptides Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Secura Takeda Pharmaceuticals North America, Inc. Trillium |
None | None | NA | 01/04/2022 |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
None | None | NA | 10/01/2021 |
| Hans Lee MD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. GlaxoSmithKline Immunitis Therapeutics Karyopharm Therapeutics Legend Biotech Monte Rosa Therapeutics Oncopeptides Pfizer Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | NA | 01/10/2022 |
| Michaela Liedtke MD | Allogene Bristol-Myers Squibb Company Caelum Celgene Corporation Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Alnylam Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kite Pharma Kura Oncology, Inc. Natera Oncopeptides sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | NA | 08/01/2021 |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GlaxoSmithKline | None | None | NA | 11/08/2021 |
| John Murphy | None | None | None | None | NA | 10/11/2021 |
| James Omel MD | None | None | None | None | NA | 10/16/2021 |
| Donna Powell DHSc,CMD,RT(T) | None | None | None | None | NA | 11/29/2021 |
| Aaron Rosenberg MD | GlaxoSmithKline | None | Takeda Pharmaceuticals North America, Inc. | None | NA | 08/20/2021 |
| Douglas Sborov MD,MSc | AbbVie, Inc. Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Pfizer Inc. sanofi-aventis U.S. |
Bristol-Myers Squibb Company GlaxoSmithKline sanofi-aventis U.S. |
Bristol-Myers Squibb Company GlaxoSmithKline sanofi-aventis U.S. |
None | NA | 01/03/2022 |
| Keith Stockerl-Goldstein MD | BioLIne Caelum Bioscineces GlaxoSmithKline Ionis Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | NA | 09/10/2021 |